The Digital Genome Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The Digital Genome Global Market Report 2025 has shown substantial growth in recent years. The market size expanded from $39.25 billion in 2024 and is projected to reach $46.94 billion in 2025. This represents a compound annual growth rate (CAGR) of 19.6%.
The Digital Genome Global Market Report 2025 predicts that by 2029, the digital genome market size will achieve a value of $97.13 billion, growing at a compound annual growth rate (CAGR) of 19.9%.
Download Your Free Sample of the 2025 Digital Genome Market Report and Uncover Key Trends Now!The key drivers in the digital genome market are:
• Increasing prevalence of genetic disorders
• Growing adoption of personalized medicine
• Developments in biotechnology
• Rising prevalence of chronic diseases
The digital genome market covered in this report is segmented –
1) By Type: Sequencing And Analyzer Instruments, Data Analysis And Management Tools
2) By Application: Diagnostics, Agriculture And Animal Research, Personalized Medicine, Drug Discovery, Treatment Analysis
3) By End User: Research Centers And Government Institutes, Academic Institutions, Pharmaceutical And Biotechnology Industries, Hospitals, Diagnostic Centers
The key trends in the digital genome market are:
• The adoption of next-generation sequencing technologies is an emerging trend in the digital genome market.
• Technological advancements are significantly shaping the future of the market.
• The extensive use of microorganisms in the diagnostics industry is a new and emerging trend.
• There is a growing trend towards the adoption of digital genomic technology by hospitals and clinics.
Major companies in the digital genome market are:
• Roche Holding AG
• Thermo Fisher Scientific Inc.
• GE HealthCare Technologies Inc.
• Quest Diagnostics
• Eurofins Scientific SE
• Agilent Technologies Inc.
• Illumina Inc.
• bioMerieux SA
• PerkinElmer Inc.
• Bio-Rad Laboratories Inc.
• Qiagen N.V.
• BGI Genomics
• Myriad Genetics Inc.
• Foundation Medicine Inc.
• ArcherDx Inc.
• Invitae Corporation
• Oxford Nanopore Technologies Ltd.
• Luminex Corporation
• GenMark Diagnostics Inc.
• NanoString Technologies Inc.
• Pacific Biosciences of California Inc.
• Genewiz
• Inscripta Inc.
• Genomic Health Inc.
• Becton Dickinson and Company
• GenomeMe
• Regeneron Pharmaceuticals Inc.
North America was the largest region in the digital genome market in 2024